Blog
3 Top Dividend Stocks to Buy During the Sell-Off
With the stock market's recent volatility, it's a good idea to build a shortlist of dividend-paying stocks to buy in the event of more sell-offs. In this context it makes sense to focus on companies
If I Had $5,000, This Is How I'd Invest It
There are so many interesting investments out there these days, and such little time -- and money, of course -- to go around. We have limited resources in more ways than one, but thankfully you can
Why Planet Fitness Is Poised for Post-Pandemic Success
Gym chains were among the countless industries upended by COVID-19. Locations were forced to shutter and still some capacity restrictions remain.
Regardless of this, one of the world's largest gym
Ulta Beauty Earnings: 3 Trends to Follow
It's been a rocky year for Ulta Beauty (NASDAQ: ULTA). The beauty products retailer and spa operator posted lower sales for 2020 as traffic at its stores stayed depressed through the first stages of
3 Reasons You Should Never Time the Stock Market
You've probably heard stories before from family members or friends who timed the market exactly. Either they sold out of an investment just before a crash or bought a stock just before it
Nordstrom's Q1 Earnings: Here's What You'll Want to Know
Nordstrom (NYSE: JWN) is slowly bouncing back from the devasting effects that the coronavirus pandemic had on its business. Recall that nearly all its stores had to shut down to in-person shopping
3 Value Stocks to Buy as Growth Stocks and Cryptocurrencies Crash
Some of the best-performing stocks of 2020 have been hit hard in recent months. Highfliers like Tesla, Peloton Interactive, Snowflake, and Zoom Video Communications have been causing investors
Pinterest Stock Has Been Hammered. Is It Still a Buy?
Pinterest (NYSE: PINS) stock has taken a beating lately and is now trading at more than 30% off its high from earlier this calendar year. The visual search and ideas social platform took off during
Okta Earnings Will Feature a Big Update to the 2021 Forecast
Okta (NASDAQ: OKTA) investors have some big questions heading into its first-quarter earnings report in a few days. The stock of the identity-management software specialist has dropped in recent
Bitcoin or Stocks: Better Buy on the Dip
The price of the world's largest cryptocurrency, Bitcoin (CRYPTO: BTC), has dropped 37% from its all-time high. As of this writing, it's trading hands at around $41,000 per token. By contrast, the
Better Buy: Verizon Communications vs. AT&T
Verizon (NYSE: VZ) and AT&T (NYSE: T) have both long been considered reliable dividend stocks for conservative investors. But over the past decade, Verizon stock generated a total return of more
Why Texas Instruments Is a Retiree's Dream Stock
Recent retirees should ignore all the noise about cryptocurrencies, NFTs, SPACs, and other speculative investments. Some of these investments might generate big short-term gains, but they're far too
These Top 3 Healthcare Dividend Stocks Will Carry You Through Any Market Mood
In the Ice Age, mammoths were fabulous beasts of their time -- so much so that some geneticists are pursuing their revival by using new technology, such as writing DNA, to clone them back into
Market Volatility Can't Touch These 2 Stocks
When Target (NYSE: TGT) sold its 1,647 pharmacies to CVS Health (NYSE: CVS) in 2015, many wondered why two companies that seemed like competitors would create a partnership. The two CEOs didn't
Here's What Warren Buffett Thinks of Robinhood
At Berkshire Hathaway's (NYSE: BRK.A)(NYSE: BRK.B) latest annual meeting, Warren Buffett had some not-so-kind things to say about the Robinhood stock trading platform. In this Fool Live video clip
Here's the Average IRA and 401(k) Balance: How Does Yours Compare?
You're probably aware that saving for retirement is crucial, and if you didn't know that, here's a gentle but necessary wake-up call. Social Security will only replace about 40% of your
Novavax Changes the Protocol for Its U.S. COVID Vaccine Study: Here's What You Should Know
Novavax (NASDAQ: NVAX) recently announced that it's changing the protocol for its pivotal late-stage study of COVID-19 vaccine candidate NVX-CoV2373. In this Motley Fool Live video recorded on May
Should You Buy NVIDIA Stock Ahead of Earnings?
NVIDIA (NASDAQ: NVDA) has been one of the best performers in the tech sector in recent years as its name has become synonymous with artificial intelligence, self-driving cars, cloud computing, and
3 Sell-Off Stocks That Could Set You Up for Life
Even as the major market indexes are topping fresh highs, there are plenty of great growth stocks out there that have been punished as some investors have turned their focus to "recovery" stocks
Tesla Kickstarted the Electric Vehicle Market: How These 3 Car Stocks Are Helping Build Its Future
The electrification of the automotive industry has hit the fast lane, and for that we have Tesla (NASDAQ: TSLA) to thank.
The company and its CEO Elon Musk are at times lightning rods for
Here's Why Everyone's Talking About Iovance Biotherapeutics
Shares of Iovance Biotherapeutics (NASDAQ: IOVA) have been on a roller-coaster ride over the past few days. That's likely because investors don't know what to make of press releases that don't quite
Is BioNTech a Buy?
If you invested $10,000 into BioNTech (NASDAQ: BNTX) stock upon its October 2019 IPO, that principal would have turned to about $125,800 as of May 21, 2021. That is several magnitudes better than
The Full Story on Warren Buffett's Portfolio, as Told by Berkshire Hathaway's 13F Filing
On Wall Street, Warren Buffett, the CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B), is an investing icon. Since taking the helm more than five decades ago, he's led his company's share price
Is Exelixis a Buy?
When it comes to biotech companies, a bird in the hand is not always worth two in the bush for shareholders. A steady drumbeat of good news from clinical-stage projects in the pipeline often makes
Is Vertex Pharmaceuticals a Buy?
In the past year, Vertex Pharmaceuticals' (NASDAQ: VRTX) stock price has fallen by 24%. That is a particularly disappointing performance, especially considering the S&P 500 rose by 40% over the same


